Ischaemic stroke - Thrombolysis;Ischämischer schlaganfall - Thrombolysetherapie

Klinikarzt

Volumn 30, Issue 1, 2001, Pages 20-24

  Nabavi, D G ^a   Ludemann P ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

rt PA; Stroke onset; Stroke unit; Thrombolysis; Vertebrobasilar ischemias

Indexed keywords

ALTEPLASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN CIRCULATION; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DRUG EFFICACY; MORTALITY; PATIENT MONITORING; RISK BENEFIT ANALYSIS; STROKE; VERTEBROBASILAR INSUFFICIENCY;

EID: 0035121365     PISSN: 03412350     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Intravenous tissue-type plaminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study
2. Thrombolytic therapy of acute basilar artery occlusion
3. Measuring cerebral blood flow using magnetic resonance imaging techniques
4. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
5. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: Randomized controlled trial
6. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA by mammalian cells
7. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian streptokinase (ASK) trial study group
8. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
9. Behandlung des akuten ischämischen insultes
10. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
11. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial
12. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach
13. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke
14. Intravenous thrombolysis with recombinant tissue plasminogen activator for of acute hemispheric stroke
15. Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease
16. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
17. Combined intravenous and intra-arterial rt-PA versus intra-arterial therapy of acute ischemic stroke. Emergency management of stroke bridging trial
18. Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke
19. CT assessment of cerebral perfusion in man. Experimental validation and initial clinical experience
20. Thrombolytic therapy for acute ischemic stroke - Summary statement
21. Akutversorgung von patienten mit zerebralen insulten. Etablierung der strukturellen voraussetzungen nötig
22. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older. The tPA stroke survey experience
23. Thrombolytic therapy with streptokinase in acute ischemic stroke
24. Tissue plasminogen activator for acute ischemic stroke
25. Thrombolytic therapy in thrombosis: A National Institute of Health consensus development conference
26. The fibrinolytic activity of hemolytic streptococci
27. Local intra-arterial fibrinolysis in the vertebrobasilar a rid carotid territories